期刊文献+

中药掺杂化学药物的分析及其对策 被引量:25

Analysis of and countermeasures against traditional Chinese medicines adulterated by synthetic drugs
在线阅读 下载PDF
导出
摘要 对中药掺杂化学药物问题的严重性、演变趋势、分析检测方法及其对策进行了综述,重点分析了此类对象的基于色谱、光谱及其他分析技术的特点。基于色谱的掺杂分析方法作为此类问题的主流分析方法,具有直观、能对掺杂化学药物进行结构确证、灵敏度较高等优点,但在快速、简便等多个指标上相对有所欠缺;基于光谱的掺杂分析方法的优缺点正与色谱方法相反,但高通量的特点尤其适合于基层打假一线对大批量样品普筛的要求;而免疫芯片等其他方法的适用性还有待扩展。作者最后对发展各种掺杂分析技术、药品监督管理的举措等提出了设想和建议。 The severity, the analysis of and the countermeasures against traditional Chinese medicines adulterated by synthetic drugs were reviewed. Importance has been attached to the introduction of the characteristics of the analytical methods based upon chromatography, spectroscopy and other techniques. As the mainstream methods of these analytes, chromatography-based methods are straightforward, sensitive and able to provide structural information, though they run short of speed and convenience. The advantages and disadvantages of the spectroscopy-based methods are exactly the other way round, making them suitable for high throughput screening of vast amount of samples. Some proposals on the development of analytical techniques and countermeasures against the phenomenon were also offered.
出处 《中国中药杂志》 CAS CSCD 北大核心 2007年第1期6-9,17,共5页 China Journal of Chinese Materia Medica
基金 上海市科学技术委员会技术标准专项(05dz05-006)
关键词 掺杂 中药 化学药物 分析 adulteration traditional Chinese medicines synthetic drugs analysis
  • 相关文献

参考文献24

  • 1张纯良,张国浩.对“梅花K”假药案的反思[J].中国药事,2004,18(1):56-58. 被引量:11
  • 2Patwardhan B,Warude D,Pushpangadan P,et al.Ayurveda and traditional Chinese medicine:A comparative overview[J].eCAM,2005,2(4):465.
  • 3Ries C A,Sahud M A.Agranulocytosis caused by Chinese herbal medicines.Dangers of medications containing aminopyrine and phenylbutazone[J].J Am Med Assoc,1975,231 (4):352.
  • 4Huang W F,Wen K C,Hsiao M L.Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan[J].J Clin Pharmacol,1997,37:334.
  • 5Ernst E.Toxic heavy metals and undeclared drugs in Asian herbal medicines[J].Trend Pharmacol Sci,2002,23(3):136.
  • 6FDA Consumer magazine.January-February 2005 Issue.http://www.fda.gov/fdac/departs/2005/105_upd.html#supplements
  • 7Yuen S,Lau-Cam C A.Thin-layer chromatographic screening procedure for undeclared synthetic drugs in Chinese herbal preparations[J].J Chromatogr,1985,329:107.
  • 8Ethier J C,Lauriault G,LeBelle M,et al.Black Pearl:identification and chromatographic determination of some undeclared medicinal ingredients[J].J Chromatogr,1989,469:406.
  • 9Liu S Y,Woo S O,Koh H L.HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances[J].J Pharm Biomed Anal,2001,24(5-6):983.
  • 10Lau A J,Holmes M J,Woo S O,et al.Analysis of adulterants in a traditional herbal medicinal product using liquid chromatographymass spectrometry-mass spectrometry[J].J Pharm Biomed Anal,2003,31 (2):401.

二级参考文献24

  • 1金声,周浣芳,常文保,慈云祥,郭振泉.酶联免疫吸附法直接测定血清雌二醇[J].分析化学,1994,22(2):115-120. 被引量:22
  • 2徐朝霞,唐树荣.高效液相色谱法测定马吲哚片含量[J].色谱,1995,13(1):72-73. 被引量:4
  • 3.中国药典[S]:二部[M].,2000.575.
  • 4FDA. Center for drug evaluation and research[ R]. Application Number 020895.1998,3:27.
  • 5Carlos G. F., Carsten A. B., Robert E. S.. Anal. Chem.[J], 2001, 73: 675-683
  • 6Hyvarinen A., Oja E.. Neural Networks[J], 2000, 13: 411-430
  • 7Hyvarinen A.. Neurocomputing[J], 1998, 22: 49-67
  • 8Hyvarinen A.. Neural Computation[J], 1999, 11(7): 1 739-1 768
  • 9Templin M F,Stoll D, Bachmann J,et al. Protein microarrays and multiplexed sandwich immunoassays: what beats the beads? Comb Chem High Throughput Screen, 2004,7 (3): 223 - 229
  • 10Mortuaire G, Marchetti P, Formstecher P, et al. Micro-array based technologies to study the proteome: technological progress and applications. Ann Biol Clin(Paris),2004,62(2): 139 - 148

共引文献151

同被引文献264

引证文献25

二级引证文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部